Transform Your Daily Lab Operations with Automation - Biomolecules Workflows
Bringing laboratory automation to life with Andrew+ and OneLab
This webinar series explores how Andrew+ automated liquid handling and OneLab workflow software support consistent, traceable and efficient laboratory operations. Through application‑focused episodes, you will see how automation can be successfully integrated into everyday laboratory workflows, from method development to routine and regulated environments, supported by real‑world customer experiences and testimonials.
Episode 2 – Biomolecules Workflows
Biomolecule workflows often involve complex and labour-intensive sample preparation steps. This episode demonstrates how automation can simplify challenging protocols while maintaining the flexibility required for method development and routine analysis, illustrated through customer examples and practical feedback.
Key highlights
- Automate demanding biomolecule workflows, including therapeutic oligonucleotides and peptides
- Simplify complex steps such as serial dilutions and liquid–liquid extraction
- Improve traceability and data integrity through structured workflow execution
Speaker: Philip Quinn (Senior Applications Specialist Chemistry Europe - Waters Corporation)
Phil started his career at Waters in 2018 as an Application Support Specialist in the Chemistry Consumables group for the UK. In his current role he is responsible for commercial pre and post-sale support for Chemistry Consumables and Automation across Europe. Prior to joining Waters, Phil worked at large Pharma organisations over 10+ years and gained extensive experience in Analytical Development and QC environments, including the Development, Optimisation, Validation and Transfer of LC methodologies
Customer Testimonials: OligoTune Ltd.
OligoTune Ltd. is a biotechnology company developing RNA oligonucleotide therapeutics for oncology applications.
In this webinar episode, OligoTune shares an end‑user perspective on biomolecule sample preparation, highlighting the challenges of handling therapeutic oligonucleotides in an R&D environment. The discussion demonstrates how automated workflows can support consistency, efficiency and traceability during biomolecule method development.
